Alpha DNA Investment Management’s Synchrony SYF Stock Holding History

Alpha DNA Investment Management’s Portfolio SYF Stock Details SYF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,318	Closed	-$1.13M	–	160
2024 Q4	$1.13M	Buy	17,318 +1,427	+9%	+$87.4K	0.43%	44
2024 Q3	$793K	Sell	15,891 -4,253	-21%	-$206K	0.3%	77
2024 Q2	$951K	Buy	+20,144	New	+$875K	0.37%	56
2023 Q1	–	Sell	-42,795	Closed	-$1.41M	–	200
2022 Q4	$1.41M	Buy	+42,795	New	+$1.47M	0.5%	38

Other funds holding SYF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alpha DNA Investment Management's SYF Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Synchrony (SYF) in Q1 2025, closing a stake of 17,318 shares — an estimated $1.13M sold.

Alpha DNA Investment Management first reported a position in SYF in Q4 2022 and held it in 4 quarters. The position peaked at $1.41M in Q4 2022. 870 funds tracked by Wall St. Rank hold SYF as of Q1 2025.

Alpha DNA Investment Management reported no remaining Synchrony position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 17,318 Synchrony shares in Q1 2025, an estimated $1.13M.
Alpha DNA Investment Management first reported a position in Synchrony in Q4 2022 and held it in 4 quarters.
Alpha DNA Investment Management's Synchrony position peaked at $1.41M in Q4 2022.
870 funds tracked by Wall St. Rank held Synchrony as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.